NIH DP5 Grants — NIH Director's Early Independence Award
Reviewed by Dr. Meng ZhaoLast reviewed June 9, 2026Data refreshed September 5, 2026Editorial standards
Skip the postdoc — direct PhD-to-PI transition
Funding
$250K direct/year
Duration
5 years
Eligibility
Recent PhDs (typically within 1 year) skipping postdoc training
Activity code
DP5
What is the NIH DP5 grant?
The DP5 funds recent PhDs (typically within 1 year of degree) who plan to skip postdoctoral training and move directly into independent positions. Awardees secure independent positions at host institutions through a competitive application process.
Recent DP5 awards from NIH RePORTER
Examples of funded DP5 projects across the last two fiscal years. The matching-award count comes from the full result set; funding totals, averages, rankings, and examples use the first 500 records returned by NIH RePORTER. Figures reflect a snapshot last refreshed on September 5, 2026.
Example DP5 projects from the sample
Deciphering Neuronal Control of Behavioral Initiation and Suppression
4DP5OD036140-04Emily Ferenczi · MASSACHUSETTS GENERAL HOSPITAL, MA · $835,000 · awarded Aug 28, 2026 · NIHPROJECT SUMMARY/ABSTRACT Nearly one million people in the USA are living with Parkinson’s disease (PD). It is a disabling neurodegenerative disease that causes progressive difficulty with movement, however equally debilitating is the progressive impairment of motivation that is experienced by most patients. Patients struggle to initiate things they want to…
Predictive modeling of viral RNA cellular behavior
4DP5OD037420-03Megan Ken · SCRIPPS RESEARCH INSTITUTE, THE, CA · $1,380,000 · awarded Aug 28, 2026 · NIHPROJECT SUMMARY/ABSTRACT Modern biomedical science enjoys an unprecedented ability to identify and describe viral pathogenic mechanisms, as well as characterize the biomolecular components that constitute them. However, we have not yet achieved a fully quantitative biophysical understanding in which modeling of component molecules is accurately predictive…
Using person-specific networks to uncover sex differences in vulnerability to internalizing disorders
4DP5OD036142-04Sheila Shanmugan · UNIVERSITY OF PENNSYLVANIA, PA · $812,500 · awarded Aug 28, 2026 · NIHPROJECT SUMMARY/ ABSTRACT Internalizing disorders such as major depressive disorder and generalized anxiety disorder show marked sex differences in prevalence, presentation, and trajectory. For example, depression and anxiety disorders are more prevalent in females than males. The neural mechanisms underlying such sex differences, however, are not well…
Transfer learning leveraging large-scale transcriptomics to map disrupted gene networks in cardiovascular disease
4DP5OD036170-04Christina Theodoris · J. DAVID GLADSTONE INSTITUTES, CA · $945,000 · awarded Aug 28, 2026 · NIHPROJECT SUMMARY/ABSTRACT Mapping the gene regulatory networks driving human disease enables the design of network-correcting treatments that target the core disease mechanism rather than merely managing symptoms. I previously developed a framework for mapping disease-dependent gene networks to enable network-based screening leveraging machine learning and…
Place-Based Influences on Mortality among People Experiencing Homelessness
5DP5OD037332-03Kaitlyn Berry · UNIVERSITY OF MINNESOTA, MN · $382,937 · awarded Aug 27, 2026 · NIHPROJECT SUMMARY/ABSTRACT Research Challenge: More than 582,000 people in the US experience homelessness each night, and a staggering 1.25 million people enter the shelter system each year. People experiencing homelessness endure extreme adversity, drastically increasing their risk of dying young. Although the response to the homelessness crisis primarily…
Decoding the Heterogeneity in Chemo-Immunomodulation to Unlock the Potential of Chemoimmunotherapy in Metastatic Triple-Negative Breast Cancer
4DP5OD036134-04Mohammed Gbadamosi · UNIVERSITY OF FLORIDA, FL · $762,500 · awarded Aug 27, 2026 · NIHPROJECT SUMMARY/ABSTRACT Triple-negative breast cancer (TNBC) is a highly heterogeneous and aggressive subtype of breast cancer characterized by the highest potential for metastasis and thus the worst clinical outcomes of all breast cancer subtypes. The outcome in metastatic TNBC (mTNBC) is particularly poor with a median overall survival time of < 16…
Decoding the beat: physiological control mechanisms for robust heart development
5DP5OD039406-02Bill Jia · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA · $410,000 · awarded Aug 27, 2026 · NIHSUMMARY A robust heartbeat is essential for vertebrate life, as it is critical for sustained transport of nutrients and waste throughout large body plans. Given this fact, the emergence and maturation of cardiac activity during embryogenesis must be extremely reliable and must be bidirectionally coordinated with development of the heart’s form. The calcium…
Deciphering the principles and mechanism of RNA structure
5DP5OD039455-02Yousuf Khan · STANFORD UNIVERSITY, CA · $385,000 · awarded Aug 27, 2026 · NIHProject Summary/Abstract: This project seeks to address the significant challenges in RNA structure, an area that remains underdeveloped despite RNA’s critical roles in various biological processes and its potential for therapeutic applications. The research is structured into three major aims, each leveraging computational and biophysical methodologies to…
Identifying transcriptomic and epigenomic convergence in intellectual and developmental disorders
4DP5OD036131-04Ryan Dhindsa · BAYLOR COLLEGE OF MEDICINE, TX · $800,000 · awarded Aug 21, 2026 · NIHProject Summary Intellectual and developmental disabilities (IDDs) cause immense suffering and affect almost 3% of the U.S. population. Nearly 1,000 IDD-associated genes have been identified, but this is far too many to study individually and develop custom therapies for each. An alternative approach is to divide IDD-associated genes into subgroups based on…
Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient Cancer
4DP5OD036128-04Susan Gueble · YALE UNIVERSITY, CT · $837,500 · awarded Aug 20, 2026 · NIHPROJECT SUMMARY/ABSTRACT Defects in DNA repair are prevalent in human cancer and present an opportunity for targeted tumor treatment with agents that induce DNA damage only in cells with specific DNA repair defects. O6-methylguanine-DNA methyltransferase (MGMT), a direct reversal repair enzyme that removes O6-alkylguanine lesions deposited by alkylating…
Dissecting the logic of mammalian gene regulation using synthetic biology and single-cell sequencing
4DP5OD036167-04Sudarshan Pinglay · UNIVERSITY OF WASHINGTON, WA · $777,500 · awarded Aug 20, 2026 · NIHPROJECT SUMMARY During development, a series of extracellular signals lead to the formation of different cell-types by inducing the differential expression of many genes. Although all genes experience the same signal, the expression of some genes is increased, some reduced, and others stay the same. Therefore, the gene expression profile that is…
Novel high-throughput approaches to discover and dissect human transcriptional protein interactions
5DP5OD039380-02Nicole DelRosso · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA · $410,000 · awarded Aug 19, 2026 · NIHPROJECT SUMMARY/ABSTRACT Understanding transcription factors in human cells is essential for insights into development, health, and disease. However, our understanding of the protein-protein interactions driving transcriptional regulation remains incomplete. While high-throughput screens have identified hundreds of effector domains within transcription…
Funding institutes in the sample
| Institute | Awards | Funding |
|---|---|---|
| NIH | 95 | $46.5M |
Most frequent institutions in the sample
- UNIVERSITY OF PENNSYLVANIA — 9 awards
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — 7 awards
- MASSACHUSETTS GENERAL HOSPITAL — 7 awards
- STANFORD UNIVERSITY — 6 awards
- WASHINGTON UNIVERSITY — 5 awards
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — 4 awards
- J. DAVID GLADSTONE INSTITUTES — 4 awards
- UNIVERSITY OF CALIFORNIA, SAN DIEGO — 3 awards
Source: NIH RePORTER. Verify any award in the official record by searching its project number. See our data methodology for how this sample is built and its limitations.
Decision guide
Choose DP5 when
Choose DP5 if you have an exceptional thesis record and a host institution willing to support an independent position immediately.
Choose another mechanism when
Most candidates benefit more from postdoctoral training and the K99/R00 path.
Who applies for DP5
Exceptional recent PhDs ready to start independent labs without postdoc training.
Compare nearby NIH grant mechanisms
Searchers often land on DP5 while deciding between adjacent NIH activity codes. Compare scope, NIH staff involvement, budget scale, and applicant stage before choosing a funding opportunity.
High-risk/high-reward research from exceptional individual scientists
Bold, untested ideas from early-stage investigators
Postdoc → faculty transition (mentored K99 then independent R00)
For broad grant lookup, use the NIH grant search to find funded examples by activity code, PI, institution, and award year.
Search tips for DP5
- DP5 awards are very rare — useful indicators of exceptional early independence trajectories.